SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000899140-20-000007
Filing Date
2020-01-03
Accepted
2020-01-02 21:59:17
Documents
1
Group Members
ALEXANDER J. DENNER, PH.D.SARISSA CAPITAL CATAPULT FUND LLCSARISSA CAPITAL HAWKEYE FUND LPSARISSA CAPITAL OFFSHORE MASTER FUND LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A, AMENDMENT #1 s32668255.htm SC 13D/A 96028
  Complete submission text file 0000899140-20-000007.txt   97721
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 225 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Subject) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87002 | Film No.: 20503285
SIC: 2834 Pharmaceutical Preparations

Mailing Address 660 STEAMBOAT ROAD GREENWICH CT 06830
Business Address 660 STEAMBOAT ROAD GREENWICH CT 06830 203-302-2330
Sarissa Capital Management LP (Filed by) CIK: 0001577524 (see all company filings)

IRS No.: 900924432 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A